Lincoln Pharmaceuticals Limited

NSE LINCOLN.NS

Lincoln Pharmaceuticals Limited Revenue Per Share for the year ending March 31, 2024: USD 3.47

Lincoln Pharmaceuticals Limited Revenue Per Share is USD 3.47 for the year ending March 31, 2024, a 12.09% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Lincoln Pharmaceuticals Limited Revenue Per Share for the year ending March 31, 2023 was USD 3.10, a 0.69% change year over year.
  • Lincoln Pharmaceuticals Limited Revenue Per Share for the year ending March 31, 2022 was USD 3.08, a 8.86% change year over year.
  • Lincoln Pharmaceuticals Limited Revenue Per Share for the year ending March 31, 2021 was USD 2.83, a 13.10% change year over year.
  • Lincoln Pharmaceuticals Limited Revenue Per Share for the year ending March 31, 2020 was USD 2.50, a -2.64% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
NSE: LINCOLN.NS

Lincoln Pharmaceuticals Limited

CEO Mr. Mahendrabhai Gulabdas Patel B.A, LLB
IPO Date Dec. 17, 2015
Location India
Headquarters Lincoln House
Employees 1,687
Sector Health Care
Industries
Description

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company's product portfolio includes dermatologist preparations, gynecological products, gastrointestinal ranges, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative. The company also offers branded generics. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Similar companies

KOPRAN.NS

Kopran Limited

USD 2.30

4.06%

RPGLIFE.NS

RPG Life Sciences Limited

USD 23.77

2.82%

ALBERTDAVD.NS

Albert David Limited

USD 14.32

5.64%

SEQUENT.NS

Sequent Scientific Limited

USD 2.07

5.03%

GUFICBIO.NS

Gufic Biosciences Limited

USD 5.42

-1.33%

StockViz Staff

January 15, 2025

Any question? Send us an email